Simcere Pharmaceutical Group Limited (02096)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Bao Jun | 10-Jun-20 | 09-Nov-22 | CoSec | ||
| 09-Nov-22 | J-CoSec | Due to his personal career development | |||
| Feng Honggang | 09-Feb-24 | NED | |||
| Feng Jie | 10-Jun-20 | 30-Jun-21 | CoSec | ||
| Mak Cherie Po Man | 17-Sep-20 | 14-Jun-24 | CoSec | ||
| Mak Po Man Cherie | 25-Mar-26 | J-CoSec | |||
| Ren Jinsheng | 30-Nov-15 | Ch, Fdr | |||
| 30-Nov-15 | 25-Mar-26 | CEO | In order to focus on the formulation of the Group’s long-term strategies, major investment decisions and overseeing the discharge of the Board’s duties. Mr. Ren will continue to serve as the Chairman and executive Director. | ||
| Song Rui Lin | 19-Nov-19 | INED | |||
| Sung Ka Woon | 18-Jan-23 | INED | |||
| Tang Renhong | 31-Dec-22 | ED | |||
| 25-May-22 | 31-Dec-22 | Co-CEO | |||
| 31-Dec-22 | Co-chief Executive Officer (Co-CEO) | Due to work rearrangement. Appointed by the Group as the chairman of the board of directors and chief executive officer of Simcere Zaiming Pharmaceutical Co., Ltd. | |||
| 19-Nov-19 | 25-May-22 | ED, SVP | |||
| Wan Yushan | 09-Nov-22 | CoSec | |||
| 19-Nov-19 | FD | ||||
| Wang Jianguo | 19-Nov-19 | INED | |||
| Wang Xi | 18-Jan-23 | ED | |||
| Wang Xinhua | 19-Nov-19 | INED | |||
| Wong Wai Ling | 14-Jun-24 | CoSec | |||
| 14-Jun-24 | 25-Mar-26 | J-CoSec | Resignation. | ||
| Zhang Cheng | 19-Nov-19 | 31-Mar-21 | COO, ED | ||
| Zhang Yi | 01-Jun-20 | NED | |||
| Zhao John Huan | 19-Nov-19 | 31-Aug-22 | NED | In order to devote more time to focus on his other business commitments |